Clopi-Denk 75

Benefits
- 75 mg clopidogrel
- Prevention and treatment of atherothrombotic events including acute coronary syndrome and thromboembolic events in atrial fibrillation
- Proven in mono, dual and triple therapy
- Antiplatelet inhibitor of choice in patients who do not undergo invasive strategies, but alternative medical treatment in ACS
- Once daily - good compliance
Documented bioequivalence
Clopi-Denk 75 in comparison with the original product:
